FDA proposes new rules for plant-based milks
GFI's Madeline Cohen summarizes FDA's draft guidance on plant-based milk labeling, and explains why consumers aren't confused when purchasing these dairy alternatives.
GFI's Madeline Cohen summarizes FDA's draft guidance on plant-based milk labeling, and explains why consumers aren't confused when purchasing these dairy alternatives.
GFI's Madeline Cohen offers insight into FDA's draft guidance on plant-based milk labeling, and its impact on consumers.
GFI responds to FDA's draft guidance on plant-based milk labeling in the U.S.
Read GFI's response to FDA's recent draft guidance on plant-based milk labeling.
GFI's Madeline Cohen discusses FDA's draft guidance on plant-based milk labeling, and how it can be detrimental to U.S. climate goals.
Join the NY Lawyer Chapter of the American Constitution Society for a conversation with GFI Senior Regulatory Attorney, Madeline Cohen, as they lead a discussion on legal, regulatory, and policy issues affecting alternatives to traditional meat products.
Join the Future of Protein Production Summit to connect virtually with alternative protein industry leaders.
GFI's Sheila Voss reflects on the importance of food sustainability and alternative proteins in global policy conversations.
Inspiring organizations and individuals around the world are reducing emissions, saving lands and waters, protecting public health, and increasing food security. Yet threats still mount. Alt proteins are essential for winning on every front.
The alternative protein industry today shows signs of resilience despite challenges across the macroeconomic landscape, geopolitical dynamics, and talent, funding, and infrastructure constraints. GFI experts predict the industry trends that will drive the next wave of developments toward mass adoption.